Register for the 6th Age-Related Disease Therapeutics Summit
Please select the appropriate price when booking. Bookings are subject to approval.
All prices are shown in USD.
Register by Friday, November 7 & Save up to $700
Drug Developer Pricing*
Conference + 2 Workshops
(Save $700)
$3,497
On the Door: $4,197
Conference + 1 Workshop
(Save $550)
$3,048
On the Door: $3,598
Conference Only
(Save $400)
$2,599
On the Door: $2,999
Academic Pricing**
Conference + 2 Workshops
(Save $700)
$2,897
On the Door: $3,597
Conference + 1 Workshop
(Save $550)
$2,548
On the Door: $3,098
Conference Only
(Save $400)
$2,199
On the Door: $2,599
Service Provider Pricing***
Conference + 2 Workshops
(Save $700)
$4,397
On the Door: $5,097
Conference + 1 Workshop
(Save $550)
$3,848
On the Door: $4,398
Conference Only
(Save $400)
$3,299
On the Door: $3,699
* To be eligible for this price, the group or individuals must be from a biotech or pharma company that has a publicly available pipeline, and does not offer pay for services.
** To be eligible for this price, the group or individual must be full-time academic(s).
*** If you are a solution or service provider, have you considered sponsoring this event? Sponsorship includes multiple passes at a discounted rate. Inquire to learn more.
Unlock Group Discounts
Maximize value for money using special team discounts: Please note that discounts are only valid when two or more delegates from one company book and pay at the same time.
10% Off
When registering 2 attendees from one company
15% Off
When registering 3 attendees from one company
20% Off
When registering 4+ attendees from one company
Need Assistance?
If you have any questions about registration pricing, discounts or would like help in the booking process, contact us and one of the team will get back to you.
Explore the Industry-Dedicated Agenda
- 40+ industry attendees
- 20+ world class speakers
- 5+ hours of dedicated networking
- 3 content-packed days from senior-level industry experts
- 2 interactive workshops with regulatory, C-suite, and investor insights
